Gilead Slumps After Cutting Earnings Outlook on Litigation Costs

United Kingdom News News

Gilead Slumps After Cutting Earnings Outlook on Litigation Costs
United Kingdom United Kingdom Latest News,United Kingdom United Kingdom Headlines

The company lowered its earnings outlook as a result of litigation costs accrued from settlements made to some plaintiffs in an antitrust lawsuit over its HIV drugs

shares erased a decline as a strong quarterly performance more than offset a lower profit outlook amid litigation costs. The stock rose as much as 1.2%.didn’t engage in an anticompetitive conspiracy

to delay generic versions of the HIV drugs. However, before the case went to trial, the companies reached a last-minute deal with major pharmacy chains and direct purchases. Gilead paid $525 million in settlements, according to a second-quarter earnings release, which shaved 32 cents off of per-share earnings.

 

United Kingdom United Kingdom Latest News, United Kingdom United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Europe markets expected to open lower as investors digest earnings and U.S. rating downgradeEurope markets expected to open lower as investors digest earnings and U.S. rating downgradeEuropean markets are expected to open lower Wednesday as investors continue to digest earnings and the U.S. rating downgrade.
Read more »



Render Time: 2025-01-09 17:28:46